Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study Describing Patients' Perception on Anticoagulant Treatment and Treatment Convenience When Treated With Pradaxa or Vitamin K Antagonist for Stroke Prophylaxis in Atrial Fibrillation.

NCT02849509 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02849509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02849509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study Describing Patients' Perception on Anticoagulant Treatment and Treatment Convenience When Treated With Pradaxa or Vitamin K Antagonist for Stroke Prophylaxis in Atrial Fibrillation.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
June 20, 2016
Completion date
December 30, 2017
Enrollment
1,313 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation